487 related articles for article (PubMed ID: 25489853)
61. Toward discovering new anti-cancer agents targeting topoisomerase IIα: a facile screening strategy adaptable to high throughput platform.
Lin YS; Huang WC; Chen MS; Hsieh TS
PLoS One; 2014; 9(5):e97008. PubMed ID: 24809695
[TBL] [Abstract][Full Text] [Related]
62. HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β.
Wilson JT; Fief CA; Jackson KD; Mercer SL; Deweese JE
Chem Res Toxicol; 2018 Feb; 31(2):137-144. PubMed ID: 29272108
[TBL] [Abstract][Full Text] [Related]
63. Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
Park S; Kadayat TM; Jun KY; Thapa Magar TB; Bist G; Shrestha A; Lee ES; Kwon Y
Eur J Med Chem; 2017 Jan; 125():14-28. PubMed ID: 27643560
[TBL] [Abstract][Full Text] [Related]
64. Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties.
Palluotto F; Sosic A; Pinato O; Zoidis G; Catto M; Sissi C; Gatto B; Carotti A
Eur J Med Chem; 2016 Nov; 123():704-717. PubMed ID: 27521587
[TBL] [Abstract][Full Text] [Related]
65. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
[TBL] [Abstract][Full Text] [Related]
66. Cobalt enhances DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
Baldwin EL; Byl JA; Osheroff N
Biochemistry; 2004 Jan; 43(3):728-35. PubMed ID: 14730977
[TBL] [Abstract][Full Text] [Related]
67. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
[TBL] [Abstract][Full Text] [Related]
68. N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison.
Bender RP; Lindsey RH; Burden DA; Osheroff N
Biochemistry; 2004 Mar; 43(12):3731-9. PubMed ID: 15035644
[TBL] [Abstract][Full Text] [Related]
69. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
70. Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.
Zhang P; Wang J; Huang H; Qiao L; Ji L; Chao H
Dalton Trans; 2013 Jun; 42(24):8907-17. PubMed ID: 23661230
[TBL] [Abstract][Full Text] [Related]
71. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
[TBL] [Abstract][Full Text] [Related]
72. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
73. The binding modes and binding affinities of epipodophyllotoxin derivatives with human topoisomerase IIα.
Naik PK; Dubey A; Soni K; Kumar R; Singh H
J Mol Graph Model; 2010 Dec; 29(4):546-64. PubMed ID: 21075653
[TBL] [Abstract][Full Text] [Related]
74. Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity.
Bender RP; Jablonksy MJ; Shadid M; Romaine I; Dunlap N; Anklin C; Graves DE; Osheroff N
Biochemistry; 2008 Apr; 47(15):4501-9. PubMed ID: 18355043
[TBL] [Abstract][Full Text] [Related]
75. 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage.
Park SE; Chang IH; Jun KY; Lee E; Lee ES; Na Y; Kwon Y
Eur J Med Chem; 2013 Nov; 69():139-45. PubMed ID: 24013413
[TBL] [Abstract][Full Text] [Related]
76. The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.
Hasinoff BB; Zhang R; Wu X; Guziec LJ; Guziec FS; Marshall K; Yalowich JC
Bioorg Med Chem; 2009 Jul; 17(13):4575-82. PubMed ID: 19457675
[TBL] [Abstract][Full Text] [Related]
77. Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα.
Silveira-Dorta G; Sousa IJ; Ríos-Luci C; Martín VS; Fernandes MX; Padrón JM
Bioorg Med Chem Lett; 2013 Oct; 23(19):5382-4. PubMed ID: 23953196
[TBL] [Abstract][Full Text] [Related]
78. Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.
Deweese JE; Guengerich FP; Burgin AB; Osheroff N
Biochemistry; 2009 Sep; 48(38):8940-7. PubMed ID: 19697956
[TBL] [Abstract][Full Text] [Related]
79. Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement.
Bandele OJ; Clawson SJ; Osheroff N
Chem Res Toxicol; 2008 Jun; 21(6):1253-60. PubMed ID: 18461976
[TBL] [Abstract][Full Text] [Related]
80. Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.
Seol Y; Gentry AC; Osheroff N; Neuman KC
J Biol Chem; 2013 May; 288(19):13695-703. PubMed ID: 23508957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]